hotspot -WSS

hotspot

author：explore 2025-09-06 02:06:40 - browse：9

Photo illustration of Fyodor Urnov surrounded by DNA strands. -- health coverage from STAT — Christine Kao/STAT

Researchers attending gene therapy meetings over the past couple years were liable to bump into a svelte, graying scientist explaining in emphatic, Russian-inflected English that the U.S. was wasting the grand potential of CRISPR gene editing.

Fyodor Urnov, the scientist in question, estimates he gave the talk 30 to 40 times: to fellow researchers, pharma executives, Food and Drug Administration officials, congressional staff, journalists, patient advocates. “Anyone who would listen,” he says.

The problem was one of scale. Sure, for-profit companies were developing cures for a small handful of genetic diseases, such as sickle cell disease. But there were hundreds of devastating conditions that CRISPR might be able to cure but that no entity was seriously working on.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Medicare Advantage enrollment hits roughly 33.4 million

focus

WSS

Large hospital system sues Multiplan for low

The perfect storm of weather conditions that led to the devastating wildfires in Maui

New study raises questions about niacin and heart health

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Timeline: Special counsel's investigation into Trump's handling of classified documents

New CMS data security rules will hurt Medicare, Medicaid research

hotspot

hotspot

explore

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

The perfect storm of weather conditions that led to the devastating wildfires in Maui

Alkermes shareholders re

Medicare Advantage enrollment hits roughly 33.4 million

Cancer drug shortages should be causing more outrage

Novo acquires Inversago for up to $1 billion

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

House GOP releases memo on Hunter Biden foreign business dealings, reviving old claims

The high cost of giving birth even with insurance

White House drug shortages task force keeps mum with Congress

focus

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

Covid's long

FDA warns medical device makers about rise in fabricated data

House GOP releases memo on Hunter Biden foreign business dealings, reviving old claims

Trump, Nauta plead not guilty to new classified docs charges but De Oliveira still not arraigned

White House drug shortages task force keeps mum with Congress

focus

hotspot

focus

hotspot